12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

  • Invacare IVC stock rose 14.3% to $0.48 during Friday's after-market session. The market value of their outstanding shares is at $18.1 million.
  • Benitec Biopharma BNTC stock increased by 11.7% to $0.19. The market value of their outstanding shares is at $5.3 million.
  • AlerisLife ALR stock moved upwards by 9.09% to $0.6. The company's market cap stands at $19.5 million.
  • Renalytix RNLX shares rose 8.55% to $2.03. The company's market cap stands at $76.0 million.
  • electroCore ECOR shares increased by 8.52% to $0.28. The market value of their outstanding shares is at $19.8 million.
  • Statera BioPharma STAB stock increased by 8.37% to $0.09. The company's market cap stands at $4.8 million.

Losers

  • Salarius Pharmaceuticals SLRX shares declined by 13.7% to $1.32 during Friday's after-market session. The company's market cap stands at $3.0 million.
  • GreenLight Biosciences GRNA stock declined by 10.17% to $1.06. The company's market cap stands at $160.6 million.
  • Intelligent Bio Solutions INBS stock decreased by 8.91% to $0.18. The market value of their outstanding shares is at $3.3 million.
  • Baudax Bio BXRX stock declined by 8.5% to $2.91. Trading volume for this security closed at 518.1K, accounting for 46.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.6 million.
  • Finch Therapeutics Group FNCH shares decreased by 8.32% to $0.44. The market value of their outstanding shares is at $21.0 million.
  • Adaptimmune Therapeutics ADAP stock declined by 7.54% to $1.35. The company's market cap stands at $221.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!